ADULT AIDS CLINICAL TRIALS UNIT

印第安纳大学建议在续展申请中建立在以下基础上：(1)科学和行政贡献。印第安纳州ACTU在科学上跻身ACTUS前20%；(2)ACTG试验的成本效益收益。印第安纳州在成本加权应计利润方面排名第三；(3)女性和少数族裔的招聘。ACTU在招募非裔美国人方面排名第二，在女性招聘方面排名第三。该网站的长期目标是：通过招募更多的研究人员，扩大科学和行政贡献；通过扩大威沙德医院的附属单位，增加妇女和少数民族的应计潜力；通过在印第安纳波利斯社区医院建立附属单位，增加患者基础。印第安纳大学ACTU的第一个具体目标是通过提交概念提案和ACTG礼宾小组和委员会的成员资格来做出科学贡献。目前，印第安纳州的调查人员在礼宾团队中拥有32个职位。建议的概念如下：(A)Eefavirenz失败的挽救治疗；(B)肛门发育不良的演变和HAART患者中HPV的作用；(C)GP 120在艾滋病毒诱导的神经细胞凋亡中在痴呆发病机制中的作用；(D)GM-CSF和CD4配体在抗包虫病和HIV-1免疫方面的作用；(E)利用体外试验研究药物与蛋白酶抑制剂的相互作用；以及(F)肠道代谢的作用和抗逆转录病毒药物的生物可获得性。第二个具体目标是扩大患者基础，包括妇女和少数族裔，但增加对威沙德医院和社区医院亚单位的支持。本申请中提议的工作将通过作为AACTG成员进行临床试验来实施，使用作为ACTU的12年来改进的基础设施。专门的免疫学、病毒学和药理学实验室将支持这项工作。

The Indiana University proposes to build upon the following in the renewal application: (1) scientific and administrative contributions. The Indiana ACTU ranks among the top 20 percent of ACTUs scientifically; (2) cost efficient accrual into AACTG trials. Indiana ranked third in cost weighed accrual; and (3) recruitment of women and minorities. The ACTU ranked second in recruitment of African- Americans and third in women. The long-term objectives of this site are to: expand scientific and administrative contributions through recruitment of additional investigators; increase accrual potential for women and minorities by expansion of the Wishard Hospital subunit; and increase the patient base by establishing a subunit at Community Hospital of Indianapolis. The first specific aim of the Indiana University ACTU is to contribute scientifically through submission of concept proposals and memberships on AACTG protocol teams and committees. Currently, Indiana investigators hold 32 positions on protocol teams. Concepts are proposed for: (a) salvage therapy for efavirenz failures; (b) evolution of anal dysplasia and the role of HPV in patients on HAART; (c) the role of gp 120 in HIV induced apoptosis of neurological cells in pathogenesis of dementia; (d) the role of GM-CSF and CD4 ligand on immunity to H. Capsulatum and HIV-1; (e) use of in vitro assays for drug interactions with protease inhibitors; and (f) the role of intestinal metabolism and bioavailability of antiretroviral drugs. The second specific aim is to expand the patient base, including women and minorities, though increased support for subunits at Wishard Hospital and Community Hospital. The work proposed in this application will be implemented through conduct of clinical trials as a member the AACTG, using an infrastructure that has been refined during 12 years as an ACTU. Specialized immunology, virology, and pharmacology laboratories will support this work.